fbpx Ata Plus - MedPlanner


MedPlanner offers the first all-in-one clinical app to manage patients. A platform that facilitates collaboration across clinicians throughout the world to overcome problems faced by the current healthcare communication by using ground-breaking app to improve patient care.

Campaign Closed RM 1,000,000 raised
125% Complete
125% of target 0 days left
Min Target RM 800,000
Max TargetRM 1,500,000


First-Mover Deal !

Within the first 30 days of the fundraising campaign and/or upon the campaign reaching 25% of its funding target, MedPlanner will reward investors with 10% additional shares from the promoters for all individual investments of RM1,255 and above.



What We Do

The Challenge

Medplanner is solving the problems of healthcare inefficiency arising from poor communication. At the heart of medical provision is team collaboration. Unfortunately, there is no good clinical communication system available. As the result, the impact of poor communication in healthcare can be seen as follows:





80% of medical mistakes and delayed treatments 





60% of medical malpractice 




Medical Establishments

Annual wastage from efficiencies; MYR 75 million in Malaysia


On daily basis, clinicians had to put up with : 

Use of Whatsapp or similar chat apps 

  • insecure for protected health information (PDPA 2010)
  • unable to conduct simultaneous/multiple case discussion risking mistakes
  • auto-download of images can jeopardize career

Archaic patient management structure

  • delays patient care for multiple teams 
  • clinical tasks confined to writing on papers risk loss of information
  • difficulties in tracking patient journey because doctors are mobile

Delays in receiving clinical updates and information

  • long process from information released by Ministry of Health
  • notices from medical directors are not directly received
  • evidence based medicine is poorly cascaded

Reference : 

  1. Wanted: a WhatsApp alternative for clinicians, British Medical Journal, February 2018
  2. Joint Commission Centre for Transforming Healthcare, June 2012
  3. Patient Safety America (PSA), Journal of Patient Safety, September 2013, A new evidence-based estimate of Patient Harms Associated with Hospital Care
  4. Health IT Outcomes, February 2016, Malpractice risks in miscommunication
  5. Journal of Healthcare Management, July 2010, Quantifying the economic impact of communication inefficiencies in US hospitals
  6. D4.org, September 2010, Inefficient Communication: a £1bn+ problems for NHS hospitals in England
  7. Mobile medical apps, lobbying in the USA, July 2013, D4.org


Our Solution

Our MedPlanner app provides the following solutions :




Security & Compliance

  • Secure access and cloud storage
  • Fully encrypted to industry standard and use of blockchain technology
  • Capture previously unrecorded information
  • Audit trail of communication




All-in-one Patient Management Tool

  • Multiple and organised concurrent case discussions
  • Easy sharing of results and clinical tasking
  • Tracking patients’ journey 
  • Referral and handover of patients




Clinical Bulletin

  • Urgent notices can be received directly by clinicians
  • Regular health announcement will not be missed
  • New guidelines on treatments can be received quickly
  • Able to share knowledge and discuss clinical subjects

Why Are We Different

  • We are the first all-in-one and comprehensive clinical app to manage patients, built from user feedback.

  • First to fill market gaps in Southeast Asia. 

  • First to incorporate bulletin feature in a clinical messaging app to cascade information from health authorities, organisations and professional bodies. 

  • Medplanner is a second-generation app built from 10 years of research and data collected from early users in the UK.

  • Our UI (User Interface) is truly clinical, sophisticated and relevant for healthcare users, but cleverly designed for ease of use.

  • Our UX (User Experience) comes with augmented tagging and AI (Artificial Intelligence) features to enable speedy patient management and to lower the risk of wrong information.

Our Revenue Model


Our Market Opportunity


Our Strategy

Our growth strategy has core elements which will primarily drive user numbers:

  • Organic Growth
  • Stimulation of Brand Awareness
  • Geographical Expansion

Our most responsive revenue needle comes from organic growth that comes from user invitations into Medplanner. Owing to the virality design of our chat app, we project that organic user acquisition via user-to-user invitations will be grow between 20% to 30% new per month at a deceearsing rate in the first 2 years in a new market. 

Medplanner’s brand personality is shows competence and reliability of our service. We leverage ion the strengths of influencers, usually lead doctors in their areas of expertise or in the or workplace to help us advocate the usage of our app. To date, several doctors from various hospitals who have used our earlier version Hailadoc have expressed their interest in implementing Medplanner as their new patient management tool.


Target Users





Indicative Usage of Funds



We are raising funds for the purpose of further product development and marketing activities. We plan to expand our current headcount of 4 team members to 9 people in 2019 to help facilitate our growth plan.


Road Map



The Team

Dr Ezam Mat Ali

Co-Founder & CEO

MedPlanner - a team messaging app and ‘filofax’ for doctors - is the brainchild of Dr Ezam Mat-Ali. He trained in the UK and worked in London as a pediatrician. In addition to being a consultant neonatologist and former head of department, he has a keen interest in how technology can improve patient care. Starting in 2009 and combining the latest high fidelity mannequins, software and modern teaching approaches, he set up the first simulation lab in London for training health professionals in emergency care and high risk scenarios. In research conducted over 70 sessions, he showed that the method significantly improved communication, team working, confidence and patient management. In 2012, he completed a Masters degree (Technology in Clinical Practice) at University College London, a curriculum which studied clinicians’ behavior interfacing with technology. Assimilating this knowledge with his clinical skills, he set out to seek a solution to the core issue in medical care - communication. His own observation identified the problems of team communication when discussing and planning patient care and potential treatment delay. Consequently, it is unsurprising that a study showed that the cost resulting from poor communication in the UK is approx. £1bn and US$ 12bn in the United States. With a team of software analyst and developers, a basic web-based prototype (Hailadoc) was developed in 2017 in the UK to enable virtual team discussions of patient cases. This concept and its MVP has proven benefit in increasing clinical efficiency, productivity and revenue. These data will be presented by a healthcare provider at a world conference on 22 March 2018 in Tel Aviv.

Ahmad Fauzi

Co-Founder & CTO

He began employment as a Management Consultant with Arthur Andersen (Accenture). As a serial entrepreneur since 1984, he has been involved in the founding of about 10 technology companies including Sapura Advanced Systems (SAS in 1991). SAS was also the developer of the leading Malaysian management Decision Support System software (EIS) at the time and the lead integrator for the Kuala Lumpur International Airport. In 2001, he founded FirstFloor Capital, Malaysia's first entrepreneur funded venture capital (VC) company. He subsequently sold FirstFloor to Khazanah Malaysia, the Malaysian sovereign fund. He left FirstFloor in 2007 to establish Singularity Ventures (Malaysia), as a privately owned and funded VC. The companies he has invested in and co-founded are in the businesses of neural software algorithms, genomic sequencing software & analytics, internet, learning management systems, drug development, semiconductors and the Internet of Things. Through Singularity Technologies, the operating company of SV, he is now in active collaboration with companies in the UK in building healthcare solutions for Assisted Living. Singularity Technologies is also a partner to Mimos, Malaysia's semiconductor R&D company in an effort to commercialize research in the country. Fauzi loves music and science fiction, and is a student of Systems Dynamics & Organizational Change.

Danil Dahlan

Co-Founder & CGO

Danil is a ‘hard-knocks’ entrepreneur with over 14 years of experience in starting, growing and selling startups. He started his career as self- taught business owner of FMCG, dealing with books and household items where he built a distribution network across South East Asia across 20 cities. He then took up a dealership with Tyco Industries Int to market home security systems and within a year using his own funneling techniques, became the highest selling ADT dealership worldwide in 2001-2003 using his methods which are now being applied in other organisations. He also started a lunchtime food court in Kuala Lumpur in 2011. He started venturing into other cross border marketing projects since 2015, where he led activation teams with the Malaysian Healthcare Tourism Council to promote Malaysian hospitals in Indonesia. He also had productive partnerships with Indonesian events and activation companies such as PT Links and BAS for short-term digital marketing projects on international events such as the Asian Games. He currently provides mentorship to startups on Lean management and growth tactical strategies.

Term Sheet

10% Additional Shares Reward

These are shares to be subscribed for and paid by the promoters i.e. the existing shareholders of Medplanner Sdn Bhd and therefore will not have impact on the valuation and any other matters pertaining to the shares offered.


Risk Disclaimer

Investing in equity crowdfunding involves certain risks that include uncertainty of returns, lack of liquidity, dilution, material events and lack of control. Investments should be done as part of a diversified portfolio. ATA PLUS offers investment opportunities to investors who understands these risks in making their own investment decisions.


This page is approved as a financial promotion by ATA PLUS Sdn. Bhd., which is authorized and regulated by the Security Commission of Malaysia. Deals that are up for investment are only offered to members of ata-plus.com on the basis of information provided by the companies concerned. ATA PLUS takes no responsibility for this information or for any recommendations or opinions made by the companies. For further information on this, please read our Term of Use.